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A B S T R A C T
The antimicrobicidal activity of the phenolic compounds in the methanolic extract of Origa-
nummajoranawas recommended.The present study aimed to investigate the protective effect
of Origanum majorana against LPS-induced toxicity in rats. Forty-eight male Sprague-Dawley
rats were randomly divided into four equal groups,with 12 rats each group. Group Cwas used
as control, while group E was treated with plant extract orally for 10 days (0.5 mg/kg/day).
Group I was given LPS at a single i.p. dose (10 mg/kg BW) and group E + I was treated with
plant extract (0.5 mg/kg/day) for 10 days, followed by a single i.p. dose of LPS (10 mg/kg BW).
The WBC count and the number of macrophages in addition to the nitric oxide level in the
peritoneal fluid were determined.Also, the lipids profile and the levels of urea and creatinine
were detected. In addition, the MDA, glutathione and total proteins, as well as AST and ALT
activities, were measured in all groups. The results indicated that the LPS injection caused
significant decrease in theWBC count, hepatic glutathione and the total proteins, as well as
serum HDL-c. On the other hand, LPS injection showed significant increase in the number of
peritoneal macrophages, the levels of nitric oxide and MDA. Moreover, the total lipids, total
cholesterol, triglycerides, urea, and creatinine concentrations, as well as AST and ALT activi-
ties, were significantly elevated. The pretreatment with Origanum majorana extract prior to
LPS antagonized and alleviated its toxic effects in the treated animals. The results indicated
that the treatment with Origanum majorana extract alone did not affect the tested param-
eters, except the number of peritoneal macrophages, which were significantly decreased.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Beni-Suef Uni-
versity. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Lipopolysaccharide (LPS) is viewed by the host as an alarmmol-
ecule indicating microbial invasion by gram-negative bacteria
pathogen (Opal, 2007). LPS triggers a global activation of in-
flammatory responses leading to liver injury in humans.
Furthermore, it was established that the inflammatory re-
sponse to LPS administration is frequently associated with
overproduction of nitric oxide, tissue injury and organ failure
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(Feihl et al., 2001; Weigand et al., 2004). The release of large
quantities of LPS into the blood stream induces a severe form
of host systemic inflammatory reactions implicated in pul-
monary, hepatic and renal failures (Wang et al., 2009).
The world nowadays has given special attention to the me-
dicinal and aromatic plants as an excellent source for bioactive
agents. Origanum majorana is a herbaceous and perennial plant
native to southern Europe and the Mediterranean (Vera and
Chane-Ming, 1999; Wang, 2014).Majorana is employed to flavor
sausages, meats, salads, and soups. Traditionally, it is used as
a folk remedy against asthma, indigestion, headache and rheu-
matism (Banchio et al., 2008; Baranauskiene˙ et al., 2006). The
methanol extract of Origanum majorana was found to have an
in vitro microbicidal activity due to the presence of 1,8-cineol,
borneol, terpinen-4-ol, p-cymene, α and β-pinene and
γ-terpinene (Hayouni et al., 2009; Muñoz et al., 2009). Monoter-
penes of marjoram as carvacrol has antibacterial, antifungal,
antispasmodic, acetylcholine esterase inhibition, radical scav-
enging effect, white blood cell macrophage stimulant and
cardiac depressant activity (Hayouni et al., 2009). It was re-
ported that Origanum majorana has potent antioxidant,
antimicrobial and anti-inflammatory effects, which are attrib-
uted to its high content of phenolic acids and flavonoids
(Banchio et al., 2008; Qari, 2008). Ursolic acid isolated from the
ethanol extract of marjoram was reported to produce anti-
tumor activities. It has been found that both oleanolic acid and
ursolic acid isolated from marjoram are effective in protect-
ing against chemically induced liver injury in laboratory animals
(Liu, 1995).
Therefore, the present study was carried out to investi-
gate (1) the alterations in the biochemical parameters, free
radicals, including NO, the number of peritoneal macrophages,
and the total white blood cells count induced by LPS in themale
rats, and (2) the role of Origanum majorana extract in alleviat-
ing the oxidative-inflammatory and hyperlipidemic effects of
LPS on the assayed parameters.
2. Materials and methods
2.1. Chemicals
Lipopolysaccharide (LPS) from Escherichia coli serotype O127:B8,
1,1,3,3-tetramethoxypropan (TMP), thiobarbituric acid (TBA),
N-(1-naphthyl)-ethylenediamine dihydrochloride (NEDD) and
vanadium III chloride (VCl3) reduced glutathione (GSH), sulfa-
nilamide (SULF), pyrogallol and 5,5-dithiobis (2-nitrobenzoic acid)
(DTNB) were purchased from Sigma-Aldrich Company, Germany.
High density lipoprotein (HDL-c), cholesterol, total lipids, tri-
glycerides (TG), urea, creatinine, aspartate aminotransferase
(AST), alanine aminotransferase (ALT) and total protein kits were
purchased from Biodiagnostic, Dokki, Giza, Egypt.
2.2. Plant extract
Origanummajorana (sweetmarjoram) was purchased from a local
herb store. The row material was a grayish-brown fine leaves
with a characteristic scent.The plant extract was prepared ac-
cording to the method of Vági et al. (2005). Dried leaves of
marjoram were extracted with 95% ethanol (1:20 w/v) using a
Soxhlet extraction method. The obtained extract was evapo-
rated under vacuum using rotary evaporator (BUCHI rotavapor,
Swiss) at 40 °C. The obtained concentrated extract was dried
over anhydrous sodium sulfate and the phenolic content was
determined using HPLC.
2.2.1. Experimental animals
Adult male albino rats of the Sprague-Dawley strain weigh-
ing 250–290 g were purchased from the National Research
Center, Dokki, Giza, Egypt. The local committee approved the
design of the experiments, and the protocol conforms to the
guidelines of the National Institutes of Health (NIH). Animals
were fed a rodent laboratory chow and water ad libitum, kept
on a 12 h light–dark cycle periods and acclimatized for at least
one week prior to the experiment.
2.2.2. Experimental design
After two weeks of acclimation, animals were divided into four
equal groups, with 12 animals each group. Group C was used
as control, while group E was treated with plant extract orally
for 10 days (0.5 mg/kg/day). Group I was given LPS at a single
i.p. dose (10 mg/kg BW) and group E + I was treated with plant
extract (0.5 mg/kg/day) for 10 days, followed by a single i.p. dose
of LPS (10 mg/kg BW). Rats were starved for 12 h and then sac-
rificed by decapitation, and the liver tissues were immediately
removed and kept at −20 °C until analysis.
2.3. Blood sampling
Blood samples were collected in tubes containing EDTA for
white blood cells count. Serum samples were prepared and
placed in a pyrogen-free Eppendorf and stored at −20 °C for
analysis.
2.3.1. Isolation of peritoneal macrophages and cell count
Immediately after decapitation of rats, cells of peritoneal mac-
rophages were isolated (Kolaczkowska et al., 2008). Cells were
centrifuged off for 10 minutes at 1200 ×g, then washed twice
with saline, and resuspended in lysis buffer (NH4Cl) for 5
minutes to lyse red blood cells. This suspension was centri-
fuged for 10 minutes at 1200 ×g and resuspended in 1.0 ml of
saline. Cell suspension counting was estimated using a he-
mocytometer. The number of viable cells was calculated and
kept constant at 1 × 106 cell/ml.
2.3.2. Determination of nitric oxide production in the
peritoneal macrophages
Diluted cell suspensions were activated according to themethod
of Kim et al. (2004).The nitric oxide concentrations were de-
termined in the isolated peritoneal macrophages after being
activated using Griess mixture (N-(1-naphthyl)-ethylenediamine
dihydrochloride and sulfanilamide; 1:1) according to themethod
of Miranda et al. (2001).The developed color wasmeasured spec-
trophotometrically at 540 nm.
2.4. Determination of nitric oxide production in the liver
homogenate
Rat liver (1 g) was homogenized in 9 ml ice cold saline using
Teflon glass homogenizer to get 10% w/v homogenate. Half
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milliliter of tissue homogenate was added to 0.5 ml of cold ab-
solute ethanol, then centrifuged at 4000 rpm for 10 minutes.
Of the supernatant, 0.3 ml was added to 0.3 ml of VCl3, fol-
lowed immediately by 0.3 ml of Griess mixture and 0.1 ml of
deionized water.The mixture was left at room temperature for
35 minutes, and then the developed color was measured spec-
trophotometrically at 540 nm. The concentration of NO was
determined using standard curve of sodium nitrite.
2.5. Determination of hepatic MDA and GSH
Lipid hydroperoxides and aldehydes in the liver homogenate
are expressed in terms of MDA equivalents, which were de-
termined according to the method of Ohkawa et al. (1979). Also,
the content of reduced glutathione in liver homogenate was
determined by Ellman’s method (Ellman, 1959).
2.6. Lipid profile
Serum total lipids, cholesterol and triglycerides (TG) were de-
termined by the methods of Zollner and Kirsch (1962), Allain
et al. (1974), and Fossati and Prencipe (1982), respectively. High
density lipoproteins (HDL) were determined according to the
method of Lopez-Virella et al. (1977).
2.7. Liver and kidney functions tests
Serum aspartate transaminase (AST; EC 2.6.1.1) and alanine
transaminase (ALT; EC 2.6.1.2) were assayed by the method of
Reitman and Frankel (1957). Hepatic total proteins were mea-
sured according to Gornall et al. (1949). Also, serum urea and
creatinine concentrations were determined by the methods of
Fawcett and Scott (1960) and Bartels et al. (1972), respectively.
2.8. Statistical analysis
Data were analyzed as a completely randomized design, and
the obtained data were subjected to one-way analysis of vari-
ance (ANOVA) using the statistical software SPSS, version 11.5.
Differences between groups were significant at P < 0.05.
3. Results
3.1. HPLC analysis of phenolic compounds
HPLC analysis revealed the presence of 3,4-dicaffeoylquinic acid
(1.37 mg/g), 4,5-dicaffeoylquinic acid (0.81 mg/g), gallic acid
(0.78 mg/g), chlorogenic acid (0.33 mg/g), rutin (0.21g/g), tannic
acid (0.45 μg/g), quercetin (0.42 μg/g), cinnamic acid (0.33 μg/g)
and phloridzin (0.05 μg/g) in the ethanolic plant extract (Fig. 1).
3.2. White blood cells count
The injection with LPS (Group I) caused a highly significant
(P < 0.01) decrease in the white blood cells count (2.6 ± 0.24 × 103)
compared to the control group (5.2 ± 0.29 × 103). On the other
hand, there was a highly significant (P < 0.01) increase in the
white blood cells in the combination group (E + I) compared
to the LPS-treated rats, while there was a non-significant
(P > 0.05) change in the white blood cells count in rats treated
Fig. 1 – HPLC analysis of phenolic compounds in Origanum majorana extract at wavelength = 320 nm.
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with the plant extract (E group) (5.2 ± 0.17 × 103) compared to
the control group (Fig. 2).
3.3. Number of peritoneal macrophages
Injection of rats with LPS caused a highly significant (P < 0.01)
increase in the number of peritoneal macrophages
(2.43 ± 0.37 × 106), whereas there was a significant (P < 0.05) de-
crease in the peritoneal macrophages in the extract-treated rats
(1.08 ± 0.15 × 106) compared to the control ones (1.36 ± 0.22 × 106).
Also, there was a significant (P < 0.05) decrease in the perito-
neal macrophages of the protected group (group E + I) compared
to the LPS-treated rats (Group I), as shown in Fig. 3.
3.4. NO levels
Our results indicated that therewas ahighly significant (P < 0.01)
increase in the hepatic NO level (3.68 ± 0.24 μmol/g tissue) of
the LPS-treated rats (Group I) compared to the control group
(0.67 ± 0.09 μmol/g tissue).Nevertheless, therewas a highly sig-
nificant (P < 0.01) decrease inhepaticNO level of the combination
group (E + I) (1.41 ± 0.10 μmol/g tissue) compared to the LPS-
injected one (Group I), as illustrated in Fig. 3. Furthermore, LPS-
injected rats had a highly significant (P < 0.01) increase in NO
level of the peritoneal macrophages (5.55 ± 1.07 μmol/l) com-
pared to the control rats (3.38 ± 0.39 μmol/l). It is noteworthy
that therewas a highly significant (P < 0.01) decrease inNO level
in the combination group (E + I) (2.82 ± 0.44 μmol/l) compared
to the LPS-treated rats (Group I), as shown in Fig. 4.
Fig. 2 – The effect of lipopolysaccharide (I), Origanum
majorana extract (E) and their combination (E + I) on the
number of white blood cells compared to a control group
(C) of male rats.
Fig. 3 – The effect of lipopolysaccharide (I), Origanum
majorana extract (E) and their combination (E + I) on the
number of peritoneal macrophages compared to a control
group (C) in male rats.
Fig. 4 – The effect of lipopolysaccharide (I), Origanum
majorana extract (E) and their combination (E + I) on the
concentration of NO (μ mol/ g tissue) in the hepatic extract
and the peritoneal macrophages compared to a control
group (C) of male rats.
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3.5. Hepatic MDA and GSH
Injection of rats with LPS caused a highly significant (P < 0.01)
increase in the MDA level (238.83 ± 15.79 nmol/g tissue), while
the rats that received plant extract had a non-significant el-
evation in the MDA level (207.33 ± 10.99 nmol/g tissue) compared
to the control ones (188.17 ± 17.70 nmol/g tissue). Addition-
ally, there was a highly significant (P < 0.01) decrease in MDA
level of the combination group (E + I) (210.17 ± 11.81 nmol/g
tissue) compared to the LPS-treated one. On the other hand,
hepatic GSH level showed a highly significant (P < 0.01) de-
crease (0.411 ± 0.077 μmol/ g tissue) in the LPS-treated rats
compared to those of control ones (0.651 ± 0.064 μmol/g tissue).
Pretreatment of rats with plant extract prior to LPS injection
led to a highly significant(P < 0.01) increase in GSH level
(0.641 ± 0.086 μmol/g tissue) compared to the LPS-treated group,
reaching that of the control levels (0.651 ± 0.064 μmol/g tissue),
as shown in Table 1.
3.6. Lipid profile
Our results showed that there was a highly significant (P < 0.01)
increase in the serum total lipids of the LPS-treated rats
(0.290 ± 0.007 g/dl), while there was a non-significant (P > 0.05)
increase in serum total lipids in rats pretreated with plant
extract (0.276 ± 0.009 g/dl) compared to that of the control
(0.272 ± 0.008 g/dl). It is noteworthy that the pretreatment of
rats with plant extract prior to LPS injection resulted in a highly
significant (P < 0.01) decrease in the total lipids (0.257 ± 0.007 g/dl)
compared to the LPS-treated group (0.290 ± 0.007 g/dl). Injec-
tion of LPS caused a highly significant (P < 0.01) increase in
serum TG (129.30 ± 7.34 mg/dl), while treatment of rats with
the plant extract resulted in a highly significant (P < 0.01) de-
crease in serumTG (95.53 ± 6.03mg/dl) compared to control ones
(111.97 ± 7.48mg/dl).Also, there was a highly significant (P < 0.01)
decrease in serum TG in the combination group (E + I,
86.40 ± 4.52 mg/dl) compared to the LPS-treated one (Table 2).
The LPS-treated rats showed a highly significant (P < 0.01)
elevation in the total cholesterol level (110.22 ± 7.19mg/dl), while
there was a non-significant (P > 0.05) increase in total choles-
terol in rats pretreated with plant extract (88.23 ± 3.80 mg/dl)
compared to that of control (84.32 ± 6.76 mg/dl). Interest-
ingly, there was a highly significant (P < 0.01) reduction in the
total cholesterol level of the combination (E + I) group
(84.20 ± 6.21 mg/dl) compared to the LPS-treated one. Differ-
ently, LPS treatment resulted in a highly significant (P < 0.01)
decrease in the HDL-c level (22.48 ± 4.65 mg/dl) and a non-
significant (P > 0.05) decrease in HDL-cholesterol in rats
pretreated with plant extract (42.92 ± 4.53 mg/dl) compared to
controls (49.32 ± 5.57 mg/dl), whereas pretreatment with plant
extract prior to LPS led to a highly significant (P < 0.01) eleva-
tion in HDL-c level (49.53 ± 4.58 mg/dl) compared to the LPS-
treated rats, normalizing its level (Table 2).
3.7. Liver and kidney functions tests
The LPS-treated rats had a highly significant (P < 0.01) in-
crease in the serum AST and ALT activities (154.22 ± 8.22 U/ml
Table 1 – The effect of lipopolysaccharide (I), Origanum majorana extract (E) and their combination (E + I) on liver
biochemical parameters compared to a control group (C) of male rats.
Parameters Experimental groups
C I E E + I
MDA (n mol/g tissue) 188.17 ± 17.70 238.83 ± 15.79a 207.33 ± 10.99a 210.17 ± 11.81a,b
GSH (μ mol/ g tissue) 0.651 ± 0.064 0.411 ± 0.077a 0.636 ± 0.114 0.641 ± 0.086b
Total proteins (g/dl) 1.45 ± 0.06 1.09 ± 0.10a 1.51 ± 0.10 1.31 ± 0.03a,b
The values are expressed as mean ± SE.
a The mean values are significantly different in comparison with control (p ≤ 0.01).
b The mean values are significantly different in comparison with the infected rats (p ≤ 0.01).
Table 2 – The effect of lipopolysaccharide (I), Origanum majorana extract (E) and their combination (E + I) on serum
biochemical parameters of male rats compared to the controls.
Parameter Experimental groups
C I E E + I
Total lipids (g/dl) 0.272 ± 0.008 0.290 ± 0.007a 0.276 ± 0.009 0.257 ± 0.007a,b
Total cholesterol (mg/dl) 84.32 ± 6.76 110.22 ± 7.19a 88.23 ± 3.80 84.20 ± 6.21b
HDL_c (mg/dl) 49.32 ± 5.57 22.48 ± 4.65a 42.92 ± 4.53 49.53 ± 4.58b
Triglycerides (mg/dl) 111.97 ± 7.48 129.30 ± 7.34a 95.53 ± 6.03a 86.40 ± 4.52a,b
AST activity (U/ml) 83.72 ± 8.86 154.22 ± 8.22a 73.87 ± 6.75 59.20 ± 7.45a,b
ALT activity (U/ml) 12.72 ± 3.38 148.03 ± 4.12a 15.32 ± 6.46 15.00 ± 4.72b
Urea (mg/dl) 33.03 ± 3.71 74.50 ± 6.67a 26.60 ± 3.41a 30.22 ± 6.79b
Creatinine (mg/dl) 0.34 ± 0.03 0.72 ± 0.05a 0.43 ± 0.05a 0.57 ± 0.02a,b
The values are expressed as mean ± SE.
a The mean values are significantly different in comparison with control (p ≤ 0.01).
b The mean values are significantly different in comparison with the infected rats (p ≤ 0.01).
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and 148.03 ± 4.12 U/ml, respectively) compared to the control
(83.72 ± 8.86 U/ml and 12.72 ± 3.38 U/ml, respectively),while plant
extract treatment did not change the activities of AST and ALT
compared to the control. Our results showed a highly signifi-
cant (P < 0.01) decrease in the activity of serumAST in the E + I
group (59.20 ± 7.45 U/ml) compared to the LPS-treated one
(154.22 ± 8.22 U/ml). Moreover, there was a significant de-
crease in serumALT activity in the (E + I) group (15.00 ± 4.72 U/
ml) compared to the LPS-treated one (154.22 ± 8.22 U/ml), as
shown in Table 2.
The results in Table 1 indicated a highly significant (P < 0.01)
decrease (1.09 ± 0.10 g/dl) in the hepatic total proteins of LPS-
treated rats, while there was a non-significant (P > 0.05) increase
in liver total proteins in rats pretreated with plant extract
(1.51 ± 0.10 g/dl) compared to that of control (1.45 ± 0.06 g/dl).
Meanwhile, there was a highly significant (P < 0.01) increase
in the hepatic total proteins in (E + I) group (1.31 ± 0.03 g/dl) com-
pared to the LPS-treated rats (1.09 ± 0.10 g/dl).
The results in Table 2 showed a highly significant (P < 0.01)
elevation in the serum urea (74.50 ± 6.67 mg/dl) and creati-
nine (0.72 ± 0.05 mg/dl) in the LPS-treated rats compared to the
control levels, whereas treatment of rats with the plant extract
prior to LPS injection significantly decreased serum urea
(30.22 ± 6.79 mg/dl) and creatinine (0.57 ± 0.02 mg/dl) com-
pared to LPS-treated group (74.50 ± 6.67 mg/dl and
0.72 ± 0.05 mg/dl, respectively).
4. Discussion
Our results revealed a significant decrease in the white blood
cells (Fig. 2) in the LPS-treated rats in response to the induced
inflammation, whereas Fig. 3 showed a significant increase in
the peritoneal macrophages in the LPS-treated rats com-
pared to the control group. These results are in coincidence
with Shin et al. (2007), who reported that the activated mac-
rophages play a central role in the regulation of the immune
and inflammatory activities in which neutrophils and mac-
rophages rapidly migrate from the blood to the sites of infection
under the effect of chemotactic factors produced by the innate
humeral immune system. This migration is evidenced by the
significant decrease in the white blood cells and the signifi-
cant increase in the peritoneal macrophages. Meanwhile, our
data confirmed a significant improvement in both white blood
cells count and peritoneal macrophages in the Origanum
majorana-treated rats. This effect may be attributed to the an-
timicrobial effect of Origanummajorana extract (Ayari et al., 2013;
Qari, 2008).
In our investigation, LPS caused highly significant in-
crease in the hepatic nitrite of the LPS-treated rats compared
to the control (Fig. 4). Abd Allah (2006) reported that the in-
jection of LPS to rats produced a marked induction of NO in
the liver tissue. This increase in the nitrite levels was ex-
plained by the activation of iNOS expression in the Kupffer cells
and the hepatocytes in response to LPS, which could impair
hepatic function by direct injury to hepatocytes (Kaur et al.,
2006). Likewise, Fig. 4 showed a high significant increase in NO
level in the peritoneal macrophages of the LPS-treated rats com-
pared to control.While NO generated by the endothelial cells
is mostly considered responsible for inflammation-induced
injury, the migration of the inflammatory cells might be the
potential source of NO at the site of inflammation (Sethi and
Dikshit, 2000). Previous study stated that the concentration of
nitrate in the circulation was proposed as a reliable marker for
the morbidity and mortality of the patients, as well as experi-
mental animals (Hwang et al., 2007).
In our study, the alcoholic extract of Origanum majorana was
found to protect rats from LPS-induced inflammation. These
anti-inflammatory properties are evidenced by the signifi-
cant decrease in NO in the liver and peritoneal fluid of group
(E + I) compared to group I. These results were found to be co-
inciding with Tunçtan et al. (2003), who found that of
cyclooxygenase inhibitors significantly decreased the serum
levels of nitric oxide and the survival in a mice model of sepsis.
HPLC analysis data indicated the presence of certain
bioactive components of Origanum majorana, such as querce-
tin, 3, 4-dicaffeoylquinic acid, 4, 5-dicaffeoylquinic acid, gallic
acid, chlorogenic acid, rutin, tannic acid, cinnamic acid and
phloridzin in the ethanolic plant extract (Fig. 1).Another working
group has affirmed that Origanum majorana contains pheno-
lic terpenoids, flavonoids, tannins, hydroquinone and phenolic
glycosides as a plausible explanation for its antitoxic and the
protective action (Yazdanparast and Shahriyary, 2008). These
constituents have inhibitory effect on the activities of
lipoxygenase, cyclooxygenase, inducible nitric oxide syn-
thase and monooxygenase (Moon et al., 2006). Quercetin and
a number of other flavonoids were found to have a free radical
scavenging and anti-inflammatory suppressing NO produc-
tion in macrophages activated by LPS in vitro (Abd El-Gawad
and Khalifa, 2001). Recently, Ayari et al. (2013) also correlated
the antioxidant and antimicrobial activities of marjoram
methanolic extract to its phenolic content. Moreover, LPS ad-
ministration significantly increased the circulating levels of
MDA, a marker of oxidative stress, which is in agreement with
other studies (Kaur et al., 2006; Minutoli et al., 2008). NO reacts
with superoxide anion (O2−) producing peroxynitrite (ONOO−),
a powerful oxidant, which damages the biological molecules,
increases lipid peroxidation, and leads to oxidative damage in
lungs, kidneys and liver tissue (Çag˘lıkülekci et al., 2004). The
response to such oxidative stress is achieved by defense mecha-
nisms, including GSH which is responsible for maintaining the
redox state of the cells.We evidenced that the hepatic GSH level
was significantly decreased in the LPS-treated rats compared
to the control (Table 1). This result was supported by the data
of Kaur et al. (2006), who found significant decrease in the liver
GSH level after LPS injection. Previous studies suggested that
NO itself may negatively regulate the antioxidative GSH system
by inhibiting GSH reductase through the formation of
S-nitrosoglutathione (Eum et al., 2006). It was observed that
there was a highly significant decrease in MDA level of the com-
bination group (E + I) compared to the LPS-treated one. On the
other hand, pretreatment of rats with plant extract prior to LPS
injection led to a highly significant increase in GSH level com-
pared to the LPS-treated group, reaching that of the control
levels. Plant constituents such as caffeic acid derivatives exhibit
various properties, such as antioxidative, antimutagenic,
anti-inflammatory and hepatoprotective effects (Fecka and
Turek, 2006). Our results indicated that the ethanolic extract
of Origanum majorana contain 3,4-dicaffeoylquinic acid,
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4,5-dicaffeoylquinic acid, gallic acid, chlorogenic acid, rutin,
tannic acid, quercetin, cinnamic acid and phloridzin as themain
polyphenols content. Lima et al. (2006) reported that these poly-
phenols attenuated the decrease in GSH level induced by tetra
butyl hydroperoxide. This explains our finding that pretreat-
ment with Origanummajorana in rats resulted in decreased MDA
level and elevated GSH level. It was reported that the admin-
istration ofmarjoram could reverse the side effects of potassium
bromate by scavenging the free radicals by the plant bioactive
antioxidant constituents (Bulbul et al., 2012).
Habibi et al. (2015) revealed that O. vulgarewith high amount
of flavonoids and phenolic compounds induces potent
hepatoprotective mechanisms.Therefore,O. vulgare might help
defend the body against side effects, particularly hepatic
damages induced by chemotherapeutic agents. Afifi et al. (2014)
indicated that oral administration of Origanum majorana plant
increased the antioxidant enzymes and significantly de-
creased liver enzyme levels when given in repeated doses.Thus,
methanolic extract of Origanum majorana possesses a signifi-
cant antioxidant activity.
Furthermore, data represented in Table 2 showed an altered
lipid metabolism represented by a significant increase in the
serum total lipids, total cholesterol and triglycerides in LPS-
treated rats compared to the control. Meanwhile, LPS treatment
caused a significant decrease in HDL-c compared to the control.
Our data are supported by the work of Crespo et al. (1999), who
found that the administration of LPS to rats was associated with
a significant rise in the serum levels of cholesterol, triglycer-
ides, aspartate and alanine aminotransferases, creatinine, and
urea. Van Oosten et al. (2001) suggested that the increased level
of serum lipoproteins may be attributed to the physiological
defense mechanism of the rat body to combat the toxic effects
of circulating LPS. They also reported that serum lipoproteins
may play an important role in the protection against infec-
tion and inflammation, binding to LPS and reducing its toxic
properties. Our study showed that Origanum majorana extract
has a lowering effect on LPS-induced hyperlipidemia and hy-
percholesterolemia; there was a significant decrease in the
cholesterol and triglycerides levels in group E + I compared to
LPS-treated rats (Table 2). Our data are in agreement with the
published data by El Ashmawy and Salama (2005), who sug-
gested that the chlorogenic acid and caffeic acid in Origanum
majorana extract may act as hypocholesterolemic agent, re-
ducing the LDL-c levels, when administrated orally to humans.
Our data confirmed a highly significant increase in the serum
activities of AST and ALT and significant decrease in the total
protein content of the LPS-treated rats compared to that of
control ones (Table 2). Pradeep et al. (2007) established that the
high serum levels of transaminases are taken as an index of
hepatic injury. Mittal et al. (2006) and Kaur et al. (2006) sug-
gested that the generation of superoxide anion (O2−), NO and
other ROS and reactive nitrogen species (RNS) accelerate
peroxidation of native membrane lipids, leading to a loss of
membrane integrity and subsequent release of the cytosolic
contents. Serum AST and ALT activities were significantly de-
creased in E + I group compared to LPS-treated group. However,
significant increase in the total proteins was noticed in both
the plant extract-treated rats and E + I group, demonstrating
the role of active ingredients in Origanum majorana in liver treat-
ment. Furthermore, Table 2 revealed a significant increase in
the levels of serum urea and creatinine in the LPS-treated rats
compared to control.The protective effect of Origanum majorana
was proven by the significant decrease in urea and creati-
nine in group E + I compared to LPS-treated rats. It could be
concluded that Origanum majorana plays an important role in
ameliorating liver and kidney functions. Shati (2011) found that
Origanum majorana-treatment alleviated all the Cd-disrupted
levels of liver biomarkers, urea, creatinine, total protein levels,
and the activities of liver and kidney antioxidants.
5. Conclusion
Ethanolic extract of Origanum majorana has been shown to
possess anti-inflammatory, antioxidative, hypolipidemic and
hepatoprotective effects against LPS-induced endotoxemia. So
it can be used as an effective and safe alternative comple-
mentary treatment.
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